Replies to post #378682 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

I don’t disagree. CEO has become more cautious as to what he communicates. R&D continues, clinical trials continue, gross margins continue to expand, etc. I’d like to see some bigger products and products that we actually keep vs selling to 3rd party. The company is growing, albeit far slower than anyone shareholder would like. I expect that shift away from Lannett will be our last major hurdle before we see faster growth driving more investments in the company. I’m cautiously optimistic about the next couple of years.